Sarcoidosis PBMC
About: Sarcoidosis PBMC samples are collected from clinically confirmed sarcoidosis donors and cryopreserved. These PBMCs are ideal for analyzing T cell subsets, cytokine production, and transcriptomic profiles related to disease activity.
| Lot Number | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 74428 | Sarcoidosis | 10M | Caucasian | 58 | Male | United States (US) |
Albuterol, Rinvoq, merbetriq, Lefludimide, Gabapentin ventiline inhaler PRN exofenydine 180mg QD topomax 50mg PRN flomax 16g QD cyclobenzapine 10mg BID Rinvoq QD duoneb (nebulizer) QD cereba inhaler BID Pepcid singulair gabapentine 300mg TID colonzapan .5mg BID hydrochlorothiazide 25mg QD
|
3 | ||
| 58002 | Sarcoidosis | 10M | Caucasian | 65 | Female | United States (US) |
dexalan 60mg QD hematryptaline 50mg BID alprazalan 0.5mg QD losartin 40mg QD brio 100mg/25 QD albuterol inhaler PRN diltyzan 240mg QD hydrocortozone 10mg BID hyoscyamine 0.125mg QD
|
7 | ||
| 56242 | Sarcoidosis | 3M | Caucasian | 65 | Female | United States (US) |
dexalan 60mg QD hematryptaline 50mg BID alprazalan 0.5mg QD losartin 40mg QD brio 100mg/25 QD albuterol inhaler PRN diltyzan 240mg QD hydrocortozone 10mg BID hyoscyamine 0.125mg QD
|
1 | ||
| 56236 | Sarcoidosis | 10M | Caucasian | 62 | Male | United States (US) |
mesalamine 1000 QD solatol 80mg BID eloquis 5mg BID prednisone 2.5mg BID methotrexate 15mg QIW synthroid .150mg QD (only 6 days/week) folic acid 1mg QD vitamins
|
3 | ||
| 56039 | Sarcoidosis | 10M | Caucasian | 22 | Female | United States (US) |
zoloft, 100mg, QD Prednisone, 20mg, QD
|
2 | ||
| 56816 | Sarcoidosis | 10M | Caucasian | 60 | Female | United States (US) |
prednisone QD humera QD
|
4 | ||
| 56331 | Sarcoidosis | 10M | Caucasian | 59 | Male | United States (US) |
Remicade
|
2 | ||
| 55123 | Sarcoidosis | 10M | Caucasian | 71 | Female | United States (US) |
Cell Cept
|
1 | ||
| 54650 | Sarcoidosis | 6M | African American | 49 | Female | United States (US) | 1 | |||
| 55271 | Sarcoidosis | 10M | Caucasian | 63 | Female | United States (US) |
ametryptoline 10mg BID atorvostatin 40mg QD eloquis 5mg BID intresto 25mg QD ferosenide 20mg QD gabapentine 300mg BID levothyroxine 125mcg QD metropolol50mg QD montelucus 1 tablet QD prednisone 5mg QD spironolactone 25mg QD
|
3 |
High-Quality Sarcoidosis PBMC for Research
Sarcoidosis Human PBMC samples products are sourced from donors clinically diagnosed with sarcoidosis and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on T cell activation, cytokine production, and transcriptomic profiles related to disease activity.
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed sarcoidosis donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified sarcoidosis diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional Sarcoidosis-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in sarcoidosis pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Sarcoidosis PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
Electronic medical records are an option to be included with the PBMC sample, as well as, flow cytometry and other phenotypic testing.
1 Answer
YES – we can often accommodate treatment-naive samples including various cancers, and you can specify immunosupression status or other requirements in the I/E criteria.
1 Answer
Self-reported infectious disease testing is always available and some of our products have additional testing.
1 Answer
HLA-typing is available for some of our PBMC products.
1 Answer
YES to both – Unique donors can be specified, and multiple vials from the same donor can be arranged. You can specify these requirements when ordering.
1 Answer
Healthy PBMCs achieve over 90% vialbity post-thaw. Although our disease-state PBMCs are processed with same stringent SOP, there is more variability depending upon disease. Learn more about our post thaw viability here. https://sanguinebio.com/pbmc-viability-quality-assurance/
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.